Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 169

1.

Comments on "Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure".

Cuttler J, Mortazavi S, Welsh J, Doss M.

Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0377. [Epub ahead of print]

PMID:
29132249
2.

Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.

An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J.

Radiother Oncol. 2017 Oct;125(1):80-88. doi: 10.1016/j.radonc.2017.08.009. Epub 2017 Sep 12.

PMID:
28916225
3.

Radiation Oncology Resident Mentorship: Results of a Resident-Coordinated Mentorship Program.

Engel S, Lischalk JW, Barry P, Hopkins S, Welsh JS, Fernandez E, Mundt AJ.

J Am Coll Radiol. 2017 Dec;14(12):1607-1610. doi: 10.1016/j.jacr.2017.07.011. Epub 2017 Aug 31. No abstract available.

PMID:
28865723
4.

Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.

Davuluri R, Jiang W, Fang P, Xu C, Komaki R, Gomez DR, Welsh J, Cox JD, Crane CH, Hsu CC, Lin SH.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):128-135. doi: 10.1016/j.ijrobp.2017.05.037. Epub 2017 Jun 1.

PMID:
28816138
5.

Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.

Kono M, Allen PK, Lin SH, Wei X, Jeter MD, Welsh JW, Cox JD, Komaki R.

J Thorac Oncol. 2017 Nov;12(11):1696-1703. doi: 10.1016/j.jtho.2017.07.030. Epub 2017 Aug 10.

PMID:
28804012
6.

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.

Chang JY, Verma V, Li M, Zhang W, Komaki R, Lu C, Allen PK, Liao Z, Welsh J, Lin SH, Gomez D, Jeter M, O'Reilly M, Zhu RX, Zhang X, Li H, Mohan R, Heymach JV, Vaporciyan AA, Hahn S, Cox JD.

JAMA Oncol. 2017 Aug 10;3(8):e172032. doi: 10.1001/jamaoncol.2017.2032. Epub 2017 Aug 10.

PMID:
28727865
7.

Comment on "Chromosomal Aberrations in Large Japanese Field Mice (Apodemus speciosus) Captured Near Fukushima Dai-ichi Nuclear Power Plant".

Mortazavi S, Bevelacqua JJ, Corrice L, Dobrzyński L, Feinendegen LE, Miller ML, Sacks B, Ulsh B, Pennington CW, Welsh J, Doss M.

Environ Sci Technol. 2017 Jul 18;51(14):8196-8197. doi: 10.1021/acs.est.7b01900. Epub 2017 Jun 27. No abstract available.

PMID:
28654249
8.

Webinar-Based Contouring Education for Residents.

Sura K, Lischalk JW, Leckie J, Welsh JS, Mundt AJ, Fernandez E.

J Am Coll Radiol. 2017 Aug;14(8):1074-1079.e3. doi: 10.1016/j.jacr.2017.03.013. Epub 2017 May 24. No abstract available.

PMID:
28551341
9.

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.

Schoenhals JE, Seyedin SN, Anderson C, Brooks ED, Li YR, Younes AI, Niknam S, Li A, Barsoumian HB, Cortez MA, Welsh JW.

Transl Lung Cancer Res. 2017 Apr;6(2):148-158. doi: 10.21037/tlcr.2017.03.06. Review.

10.

Dose Optimization to Minimize Radiation Risk for Children Undergoing CT and Nuclear Medicine Imaging Is Misguided and Detrimental.

Siegel JA, Sacks B, Pennington CW, Welsh JS.

J Nucl Med. 2017 Jun;58(6):865-868. doi: 10.2967/jnumed.117.195263. Epub 2017 May 10. Review.

PMID:
28490467
11.

Androgen Deprivation Therapy and Subsequent Dementia.

Welsh JS, Hentz C.

JAMA Oncol. 2017 Jul 1;3(7):1000-1001. doi: 10.1001/jamaoncol.2016.5854. No abstract available.

PMID:
28472302
12.

Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer.

Fang P, Swanick CW, Pezzi TA, Liao Z, Welsh J, Lin SH, Gomez DR.

Pract Radiat Oncol. 2017 Nov - Dec;7(6):433-441. doi: 10.1016/j.prro.2017.03.005. Epub 2017 Mar 9.

PMID:
28428017
13.

7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.

Sun B, Brooks ED, Komaki RU, Liao Z, Jeter MD, McAleer MF, Allen PK, Balter PA, Welsh JD, O'Reilly MS, Gomez D, Hahn SM, Roth JA, Mehran RJ, Heymach JV, Chang JY.

Cancer. 2017 Aug 15;123(16):3031-3039. doi: 10.1002/cncr.30693. Epub 2017 Mar 27.

PMID:
28346656
14.

Optimizing Radiotherapy with Immunotherapeutic Approaches.

Schoenhals JE, Skrepnik T, Selek U, Cortez MA, Li A, Welsh JW.

Adv Exp Med Biol. 2017;995:53-71. doi: 10.1007/978-3-319-53156-4_3. Review.

PMID:
28321812
15.

Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.

Sun B, Brooks ED, Komaki R, Liao Z, Jeter M, McAleer M, Balter PA, Welsh JD, O'Reilly M, Gomez D, Hahn SM, Sepesi B, Rice DC, Heymach JV, Chang JY.

J Thorac Oncol. 2017 Jun;12(6):983-992. doi: 10.1016/j.jtho.2017.02.018. Epub 2017 Mar 1.

PMID:
28259750
16.

Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.

Brooks ED, Sun B, Zhao L, Komaki R, Liao Z, Jeter M, Welsh JW, O'Reilly MS, Gomez DR, Hahn SM, Heymach JV, Rice DC, Chang JY.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):900-907. doi: 10.1016/j.ijrobp.2016.12.022. Epub 2016 Dec 21.

PMID:
28258887
17.

Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.

Logan JK, Tang C, Liao Z, Lee JJ, Heymach JV, Swisher SG, Welsh JW, Zhang J, Lin SH, Gomez DR.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):770-777. doi: 10.1016/j.ijrobp.2016.11.035. Epub 2016 Nov 27.

PMID:
28244413
18.

Response to Comments by Drs Hamaoka and Beyea on "The Birth of the Illegitimate Linear No-Threshold Model: An Invalid Paradigm for Estimating Risk Following Low-dose Radiation Exposure".

Siegel JA, Sacks B, Pennington CW, Welsh JS.

Am J Clin Oncol. 2017 Feb;40(1):106-107. doi: 10.1097/COC.0000000000000357. No abstract available.

PMID:
28106686
19.

Phase I Trial: SABR and Ipilimumab-Response.

Tang C, Welsh JW, Hong D.

Clin Cancer Res. 2017 Jan 1;23(1):321. doi: 10.1158/1078-0432.CCR-16-2621. No abstract available.

PMID:
28049161
20.

Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.

Reddy JP, Tang C, Shih T, Kim B, Kim C, Nguyen QN, Welsh J, Benveniste M, Zhang J, Liao Z, Gomez DR.

Clin Lung Cancer. 2017 Mar;18(2):141-148. doi: 10.1016/j.cllc.2016.11.003. Epub 2016 Nov 10.

PMID:
27913215

Supplemental Content

Loading ...
Support Center